Robeco Institutional Asset Management B.V. Has $45.43 Million Holdings in Amdocs Limited $DOX

Robeco Institutional Asset Management B.V. raised its stake in Amdocs Limited (NASDAQ:DOX) by 6.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 553,738 shares of the technology company’s stock after acquiring an additional 32,494 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Amdocs were worth $45,434,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. bought a new stake in Amdocs during the third quarter worth about $26,000. Rossby Financial LCC acquired a new position in shares of Amdocs during the second quarter worth approximately $41,000. Caitong International Asset Management Co. Ltd grew its stake in shares of Amdocs by 537.8% during the second quarter. Caitong International Asset Management Co. Ltd now owns 472 shares of the technology company’s stock valued at $43,000 after purchasing an additional 398 shares during the last quarter. Neo Ivy Capital Management bought a new position in Amdocs in the 2nd quarter valued at $54,000. Finally, Geneos Wealth Management Inc. boosted its holdings in Amdocs by 213.9% in the first quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company’s stock valued at $64,000 after acquiring an additional 477 shares during the last quarter. 92.02% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on DOX shares. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research report on Thursday, October 30th. Bank of America reduced their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Stifel Nicolaus dropped their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. Wall Street Zen cut Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, January 3rd. Finally, Wolfe Research reaffirmed a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Amdocs has an average rating of “Moderate Buy” and a consensus price target of $97.00.

Amdocs Price Performance

Amdocs stock opened at $82.67 on Thursday. The company has a market capitalization of $8.92 billion, a PE ratio of 16.37, a P/E/G ratio of 1.39 and a beta of 0.40. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.23. The stock has a 50-day moving average price of $79.41 and a two-hundred day moving average price of $83.80. Amdocs Limited has a 12 month low of $74.32 and a 12 month high of $95.41.

Amdocs Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be given a dividend of $0.527 per share. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. Amdocs’s payout ratio is presently 41.58%.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.